• Online CME Courses
  • Webinar recorded
  • Oncology
Prostate cancer is the most common cancer in men in the United States and will affect 1 in every 6 men 65 years and older. Fortunately, when detected early, it is very treatable.
0
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
  • Online CME Courses
  • Webinar recorded
  • Oncology
Neuroendocrine neoplasms are rare tumors that display marked heterogeneity with varying natural history, biological behavior, response to therapy and prognosis.
0
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
  • Online CME Courses
  • Webinar recorded
  • Oncology
The 13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego provides an invaluable educational experience highlighting the latest advances in malig
0
  • 3.00 AMA PRA Category 1 Credit
  • 3.00 Attendance
  • Online CME Courses
  • Webinar recorded
  • Hematology
  • Oncology
Leukemia is a heterogeneous group of hematologic malignancies that arise from the dysfunctional proliferation of developing leukocytes.
0
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
  • Online CME Courses
  • Primary Care
  • Oncology
This education is to provide best practices related to current topics in primary care.
0
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
  • Online CME Courses
  • Oncology
  • Neurology & Neurologic Surgery
This activity will help providers understand the role of the neurosurgeon in caring for patients with brain tumors.
0
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
  • Online CME Courses
  • Dermatology
  • Oncology
This lecture will focus on common types of precancerous and cancerous conditions. We will discuss risk factors and patterns of solar behavior for basal cell carcinoma and squamous cell carcinoma.
0
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Attendance
  • Online CME Courses
  • Webinar recorded
  • Dermatology
  • Oncology
Melanoma is the third most common cutaneous malignancy after basal cell carcinoma and squamous cell carcinoma.
0
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance